Flexion Therapeutics acquired by Pacira BioSciences
Pacira BioSciences agreed to acquire Flexion Therapeutics, a US life sciences brand, on Oct 11, 2021.
Transaction summary
- Target
- Flexion Therapeutics
- Acquirer
- Pacira BioSciences
- Seller
- -
- Announced
- 2021-10-11
- Geography
- United States
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-06-19
- Latest update
- 2026-06-19
Value and multiples
100% enterprise value
Undisclosed
Value not disclosed
Basis: FundComb estimate
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
11x
EBITDA basis not stated
Basis: FundComb estimate
Basis
- Enterprise value is unavailable.
- EV / EBITDA: 11x.
- EV/EBITDA is estimated.
- EBITDA basis was not stated in the source material.
Source summary
Pacira BioSciences to Acquire Flexion Therapeutics Further - GlobeNewswire
ConfirmedContinue your research
Related transaction comps
Consumer Health
4E Therapeutics acquired by Eli Lilly and Company
2026-06-16 · Confirmed
View transaction → Consumer HealthBiofreeze acquired by Reckitt Benckiser Group plc
2021-02-01 · Confirmed
View transaction → Consumer HealthSPR Therapeutics acquired by Medtronic
2026-05-20 · Confirmed
View transaction → Life SciencesXOMA acquired by Ligand
2026-04-27 · Confirmed
View transaction →